Pioglitazone could induce remission in major depression: a meta-analysis

BACKGROUND: Pioglitazone, a selective agonist of the nuclear transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-γ), prescribed for the treatment of type 2 diabetes, could have antidepressant properties. However, its potential to induce remission of major depressive episodes,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuropsychiatr Dis Treat
Huvudupphovsmän: Colle, Romain, de Larminat, Delphine, Rotenberg, Samuel, Hozer, Franz, Hardy, Patrick, Verstuyft, Céline, Fève, Bruno, Corruble, Emmanuelle
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2016
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5182046/
https://ncbi.nlm.nih.gov/pubmed/28031713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S121149
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk